[HTML][HTML] Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin, S Nunez-Cruz… - Nature biomedical …, 2022 - nature.com
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell
haematologic malignancies. The manufacturing of these T cells typically involves their …
haematologic malignancies. The manufacturing of these T cells typically involves their …
Rapid manufacturing of non-activated potent CAR T cells
G Saba, JS Durgin, S Nunez-Cruz… - Nature Biomedical …, 2022 - search.proquest.com
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell
haematologic malignancies. The manufacturing of these T cells typically involves their …
haematologic malignancies. The manufacturing of these T cells typically involves their …
Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin… - Nature biomedical …, 2022 - pubmed.ncbi.nlm.nih.gov
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell
haematologic malignancies. The manufacturing of these T cells typically involves their …
haematologic malignancies. The manufacturing of these T cells typically involves their …
[引用][C] Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin, S Nunez-Cruz, J Patel… - Nature Biomedical …, 2022 - cir.nii.ac.jp
Rapid manufacturing of non-activated potent CAR T cells | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[HTML][HTML] Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin, S Nunez-Cruz… - Nature Biomedical …, 2022 - ncbi.nlm.nih.gov
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell
haematologic malignancies. The manufacturing of these T cells typically involves their …
haematologic malignancies. The manufacturing of these T cells typically involves their …
[PDF][PDF] Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin, S Nunez-Cruz, J Patel… - depressiongenetics.med.upenn.edu
Results Transduction of non-activated T cells by lentiviral vectors. We confirmed the
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …
[PDF][PDF] Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin, S Nunez-Cruz, J Patel… - med.upenn.edu
Results Transduction of non-activated T cells by lentiviral vectors. We confirmed the
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …
Rapid manufacturing of non-activated potent CAR T cells.
S Ghassemi, JS Durgin, S Nunez-Cruz… - Nature Biomedical …, 2022 - europepmc.org
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell
haematologic malignancies. The manufacturing of these T cells typically involves their …
haematologic malignancies. The manufacturing of these T cells typically involves their …
[PDF][PDF] Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin, S Nunez-Cruz, J Patel… - depressiongenetics.med.upenn.edu
Results Transduction of non-activated T cells by lentiviral vectors. We confirmed the
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …
[PDF][PDF] Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, JS Durgin, S Nunez-Cruz, J Patel… - academia.edu
Results Transduction of non-activated T cells by lentiviral vectors. We confirmed the
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …
previously reported low transduction efficiency of freshly isolated quiescent T cells with VSV …